Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Phase IIa study of AD-237 in treatment of COPD shows positive results

May 19, 2004

Novel potent tryptase inhibitor described by BMS

May 19, 2004

BMS scientists describe new chemokine CCR3 ligands for asthma and other disorders

May 17, 2004

AstraZeneca researchers design novel CCR3 modulators/H1 antagonists

May 13, 2004

Pfizer scientists identify novel CRTh2 antagonists

May 13, 2004

New indole-based beta2-adrenoceptor agonists in early development at Pfizer

May 13, 2004

New PDE7 inhibitors in early development at Pfizer

May 11, 2004

Inhibition of cytokine release with JTE-607 attenuates acid-induced lung injury

May 11, 2004

Novel antihistaminic agents in early development at Sumitomo

May 7, 2004

Peripherally acting antitussive agents claimed by Tsumura scientists

May 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...